Funding Opportunities

December 18, 2015 | by City of Hope

INTRAMURAL FUNDING OPPORTUNITIES

________________________________________

THE HOPE PORTFOLIO FUND

The Hope Portfolio Fund is an internal granting initiative launched faculty-wide in October 2014. It is a potential funding source for translational research projects being developed for commercial availability (e.g., FDA approval), which have established proof of concept and need gap funding not available through external grants.

Project briefs are required for prescreening.  Please submit a one page PowerPoint template followed by a one to two page description of the project. Project briefs should be submitted to Nina Paciotti by January 8, 2016.  Project briefs will be reviewed by the Internal SPOC Committee to determine which projects will continue to full submission. The SPOC review meeting for approved applications will be held on April 26, 2016. 

Project Brief Deadline: January 8, 2016

 

FOUNDATION GRANT HIGHLIGHTS

For more information or to apply for a foundation grant, please contact Barbara Romero ([email protected]) or Noëlle Gervais ([email protected]).

________________________________________

Tower Cancer Research Foundation

Career Development Grant

Amount$100,000 for one year

DeadlineFebruary 1, 2016

Applicants must have completed two years of training in an accredited fellowship program in hematology-oncology but cannot be beyond the first two years of a junior faculty appointment (A junior faculty position is not required).

 

Senior Investigator Grant

Amount$100,000 per year for five years

DeadlineFebruary 1, 2016

For the Jessica M. Berman Senior Investigator Grant, preference will be given to bio-medical research projects that relate to the etiology, mechanisms, and treatment of breast cancer including projects related to the development of early breast cancer detection devices.

The Tower Senior Investigator Grant will be awarded to a senior investigator conducting bio-medical research on important mechanisms applicable to cancer in general.

________________________________________

Sarcoma Foundation of America

The Sarcoma Foundation of America is accepting applications from investigators interested in translational science sarcoma research. Funding is available to cover equipment and supplies in support of research on the etiology, molecular biology, pathogenesis, diagnosis, and treatment of human sarcomas. Applications will only be accepted that focus on the following areas of research: omic characterization of sarcomas and definition of novel targets; omic patterns of sensitivity and resistance to existing agents; systemic therapy combinations; immunotherapy.

Amount$50,000 to cover equipment and supplies

Deadline: February 1, 2016, at 5 pm ET

________________________________________

Pancreatic Action Network

Pancreatic Cancer Action Network Research Acceleration Network-2 Grant

Amount$2,000,000 for up to three years

DeadlineJanuary 15, 2016, 12 Noon, EST

Supports a phase II treatment clinical trial or robust nontherapeutic trial, involving at least two institutions and having strong potential to contribute to the goal of doubling pancreatic cancer survival by the year 2020.

 

Pancreatic Cancer Action Network Research Acceleration Network Grant

Amount$1,000,000 for up to three years

DeadlineJanuary 15, 2016, 12 Noon, EST

Supports a project that includes a clinical component, involving at least two institutions and having strong potential to contribute to the goal of doubling pancreatic cancer survival by the year 2020.

 

Pancreatic Cancer Action Network Translational Research Grant

Amount$300,000 for two years

DeadlineJanuary 29, 2016, 12 Noon, EST

Supports an independent investigator leading a cross-disciplinary team conducting translational research that has as its endpoint the development of a pancreatic cancer assessment, prevention or treatment modality.

________________________________________

Neuroendocrine Tumor Research Foundation-AACR

The Neuroendocrine Tumor Research Foundation-AACR Grant represents a joint effort to promote and support innovative cancer research. This grant is available to full time, independent junior and senior investigators to develop and study new ideas and innovative approaches that have direct application and relevance to neuroendocrine tumors.  Proposed research may be in any discipline of basic, translational, clinical or epidemiological cancer research. Applications are invited from researchers currently in the field as well as investigators with experience in other areas of cancer or biomedical research who have promising ideas and approaches that can be applied to neuroendocrine tumor research.

Amount: $250,000 over two years

Deadline: Tuesday, January 12, 2016, 12 noon, EST

________________________________________

Kure-It-AACR

The Kure-It-AACR Research Grant for Immunotherapy in Kidney Cancer represents a joint effort to promote and support innovative cancer research. This grant is available to full time, independent junior and senior investigators to study immunological aspects of, or treatments for, kidney cancer. Research projects should advance the basic knowledge of tumor immunology mechanisms, or develop new concepts in the treatment, control, or prevention of kidney cancer by immunology-based therapeutic approaches. Proposed projects may be basic, translational, clinical, or epidemiological in nature and must focus on cancer immunology including, but not limited to: immune recognition, regulation, tumor escape, and therapeutic manipulation for kidney cancer. Applications are invited from researchers currently in the field as well as investigators with experience in other areas of cancer or biomedical immunology research who have promising ideas and approaches that can be applied to kidney cancer research.

Amount: $250,000 over two years

Deadline: Tuesday, January 12, 2016, at noon U.S. Eastern Time

 

OTHER FUNDING OPPORTUNITIES HIGHLIGHTS

For the most up-to-date list of governmental and other grants available, please CLICK HERE. If you have any questions about specific policy changes or if you have interest in applying to a specific funding opportunity, please contact your grants manager in the Office of Sponsored Research.

If you would like assistance with scientific editing of a grant proposal, please contact Keely Walker, Ph.D., ([email protected]) or Chris Gandhi, Ph.D., ([email protected]) in the Office of Faculty and Institutional Support.

________________________________________

NCI Research Specialist Award (R50)

The Research Specialist Award is designed to encourage the development of stable research career opportunities for exceptional scientists who want to pursue research within the context of an existing cancer research program, but not serve as independent investigators.  These scientists, such as researchers within a research program, core facility managers, and data scientists, are vital to sustaining the biomedical research enterprise.  The Research Specialist Award is intended to provide desirable salaries and sufficient autonomy so that individuals are not solely dependent on grants held by Principal Investigators for career continuity.

Application budgets may request the following two expenses in direct costs per year for up to 5 years: up to 100% salary support (not to exceed the NIH Legislatively-mandated Salary Cap) for the research specialist and commensurate with their level of effort on NCI-funded research grants; travel costs to attend research meetings/conferences not to exceed $5,000 per year.

Sponsor: National Cancer Institute

Letter of Intent Deadline: January 9, 2016

Deadline: February 9, 2016

________________________________________

Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21)

Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01)

Collaborative applications are encouraged that will contribute to the identification and characterization of patients at risk of developing cancer treatment-related cardiotoxicity. The primary intent is to mitigate cardiovascular dysfunction while optimizing cancer outcomes. To accomplish this, methods that evaluate cardiac risk prior to treatment and integrate evidence-based cancer treatment regimens with screening, diagnostic, and/or management strategies are sought. Research applications should focus on mitigation/management of adverse effects associated with anti-cancer treatments including: cytotoxic chemotherapies, targeted agents, immunomodulatory therapies and radiation (that occur during cancer treatment and/or long-term survivorship) as defined by cardiac specific common terminology criteria for adverse events.

Sponsor: National Cancer Institute

Deadline: Standard dates apply

________________________________________

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21)

Proposals are sought which establish the feasibility of technologies, techniques or methods that: 1) explore a new multidisciplinary approach to a biomedical challenge; 2) are high-risk but have high impact; and 3) develop data that may lead to significant future research. An EBRG application may propose hypothesis-driven, discovery-driven, developmental, or design-directed research and is appropriate for evaluating unproven approaches for which there is minimal or no preliminary data.

Sponsor: National Cancer Institute

Deadline: Standard dates apply

________________________________________

Breast Cancer and the Environment Communication Research Initiative (R21)

Breast Cancer and the Environment Communication Research Initiative (R03)

This funding opportunity encourages research projects focused on the process of effective communication of research findings about breast cancer and the environment. A central objective of this new initiative is to ensure that risk messaging is designed for dissemination and effectively implemented, and leads to individual behavior change or policy change. The ultimate goal is to provide the development, dissemination, and implementation communication-based prevention efforts to reduce the risk for breast cancer from environmental factors.

Sponsors: National Cancer Institute

Letter of Intent Deadline: January 10, 2016

Deadline: February 10, 2016

You may also be interested in

Back To Top

Search Blogs